29.52
price down icon2.09%   -0.535
 
loading
전일 마감가:
$30.05
열려 있는:
$30.24
하루 거래량:
1.62M
Relative Volume:
0.66
시가총액:
$3.73B
수익:
$715.22M
순이익/손실:
$-250.10M
주가수익비율:
-14.54
EPS:
-2.03
순현금흐름:
$-205.58M
1주 성능:
+4.55%
1개월 성능:
+29.90%
6개월 성능:
+61.57%
1년 성능:
+7.34%
1일 변동 폭
Value
$29.39
$30.44
1주일 범위
Value
$28.05
$30.48
52주 변동 폭
Value
$16.10
$35.72

아펠리스 Stock (APLS) Company Profile

Name
명칭
Apellis Pharmaceuticals Inc
Name
전화
617-977-5700
Name
주소
100 FIFTH AVENUE, WALTHAM, KY
Name
직원
710
Name
트위터
@ApellisPharma
Name
다음 수익 날짜
2024-12-05
Name
최신 SEC 제출 서류
Name
APLS's Discussions on Twitter

APLS을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
APLS
Apellis Pharmaceuticals Inc
29.52 3.80B 715.22M -250.10M -205.58M -2.03
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
417.04 108.30B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
651.82 69.37B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
478.88 62.38B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
ARGX
Argen X Se Adr
823.87 51.50B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
165.48 34.94B 398.11M -1.03B -868.57M -5.7032

아펠리스 Stock (APLS) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-10-15 개시 Wells Fargo Overweight
2025-09-26 다운그레이드 Goldman Neutral → Sell
2025-05-09 다운그레이드 BofA Securities Buy → Neutral
2025-05-09 다운그레이드 Raymond James Strong Buy → Outperform
2025-04-29 개시 Cantor Fitzgerald Overweight
2024-12-17 다운그레이드 Goldman Buy → Neutral
2024-11-21 개시 Morgan Stanley Equal-Weight
2024-10-25 개시 RBC Capital Mkts Sector Perform
2024-10-16 개시 Scotiabank Sector Outperform
2024-10-16 개시 William Blair Outperform
2024-05-31 개시 Piper Sandler Neutral
2024-02-05 업그레이드 Jefferies Hold → Buy
2023-12-14 다운그레이드 Wells Fargo Overweight → Equal Weight
2023-11-09 개시 Goldman Buy
2023-11-02 개시 Mizuho Neutral
2023-10-06 업그레이드 JP Morgan Neutral → Overweight
2023-09-15 업그레이드 Wells Fargo Equal Weight → Overweight
2023-08-29 재확인 Citigroup Buy
2023-08-03 다운그레이드 JP Morgan Overweight → Neutral
2023-08-01 다운그레이드 BofA Securities Buy → Neutral
2023-01-03 다운그레이드 Wells Fargo Overweight → Equal Weight
2022-11-10 다운그레이드 Jefferies Buy → Hold
2022-07-19 개시 H.C. Wainwright Buy
2022-06-17 재개 Stifel Buy
2022-04-14 다운그레이드 ROTH Capital Neutral → Sell
2021-12-08 개시 Wells Fargo Overweight
2021-11-29 다운그레이드 ROTH Capital Buy → Neutral
2021-09-10 재확인 BMO Capital Markets Outperform
2021-09-10 재확인 Credit Suisse Neutral
2021-09-10 재확인 Needham Buy
2021-09-10 재확인 Oppenheimer Outperform
2021-09-10 다운그레이드 Wedbush Outperform → Neutral
2021-08-19 개시 Jefferies Buy
2021-08-19 업그레이드 Wedbush Neutral → Outperform
2021-05-21 개시 UBS Buy
2021-04-16 개시 Goldman Buy
2020-11-19 개시 Needham Buy
2020-09-01 개시 Stifel Buy
2020-07-20 개시 ROTH Capital Buy
2020-06-17 개시 BTIG Research Neutral
2020-04-01 개시 Raymond James Strong Buy
2020-03-31 개시 BMO Capital Markets Outperform
2020-03-11 업그레이드 Wedbush Underperform → Neutral
2020-01-07 개시 SVB Leerink Mkt Perform
2019-12-19 개시 BofA/Merrill Buy
2019-11-22 개시 Wedbush Underperform
2019-11-05 개시 Credit Suisse Neutral
2019-08-01 재확인 Cantor Fitzgerald Overweight
2019-07-12 업그레이드 JP Morgan Neutral → Overweight
2019-03-29 개시 Robert W. Baird Outperform
2019-01-23 다운그레이드 JP Morgan Overweight → Neutral
2018-07-30 업그레이드 B. Riley FBR Neutral → Buy
2018-05-24 개시 Cantor Fitzgerald Overweight
2018-04-12 다운그레이드 B. Riley FBR, Inc. Buy → Neutral
2018-02-08 개시 B. Riley FBR, Inc. Buy
모두보기

아펠리스 주식(APLS)의 최신 뉴스

pulisher
09:07 AM

Earnings To Watch: Apellis Pharmaceuticals Inc (APLS) Reports Q3 2025 Result - GuruFocus

09:07 AM
pulisher
06:59 AM

Apellis Pharmaceuticals Inc. recovery potential after sell offJuly 2025 Movers & Reliable Entry Point Alerts - newser.com

06:59 AM
pulisher
03:11 AM

Published on: 2025-10-29 02:11:34 - newser.com

03:11 AM
pulisher
01:55 AM

How moving averages guide Apellis Pharmaceuticals Inc. tradingJuly 2025 Pullbacks & Capital Protection Trading Alerts - newser.com

01:55 AM
pulisher
Oct 28, 2025

Why retail investors favor Apellis Pharmaceuticals Inc. stockJuly 2025 Trends & Stepwise Entry and Exit Trade Signals - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 28, 2025

Apellis Pharmaceuticals Inc. stock prediction for this weekQuarterly Profit Summary & Long-Term Capital Growth Ideas - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Will a bounce in Apellis Pharmaceuticals Inc. offer an exitWeekly Gains Summary & Safe Entry Point Identification - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Is Apellis Pharmaceuticals Inc. stock attractive for income investorsEarnings Risk Report & Risk Managed Investment Entry Signals - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Will breakout in Apellis Pharmaceuticals Inc. lead to full recoveryLong Setup & Detailed Earnings Play Alerts - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Regression analysis insights on Apellis Pharmaceuticals Inc. performancePortfolio Return Report & Entry and Exit Point Strategies - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Does Apellis Pharmaceuticals Inc. (1JK) stock trade below intrinsic valueQuarterly Performance Summary & Technical Entry and Exit Tips - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

What valuation ratios show for Apellis Pharmaceuticals Inc. (1JK) stockMarket Performance Recap & Advanced Technical Signal Analysis - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Will Apellis Pharmaceuticals Inc. (1JK) stock rise with strong economyWeekly Gains Report & AI Powered Market Trend Analysis - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Will Apellis Pharmaceuticals Inc. stock maintain dividend yieldJuly 2025 Trade Ideas & Stock Timing and Entry Methods - newser.com

Oct 28, 2025
pulisher
Oct 27, 2025

Real time scanner hits for Apellis Pharmaceuticals Inc. explainedWeekly Trade Report & High Yield Equity Trading Tips - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

What high frequency data says about Apellis Pharmaceuticals Inc.Market Risk Analysis & Consistent Return Strategy Ideas - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Can Apellis Pharmaceuticals Inc. (1JK) stock survive global slowdownQuarterly Trade Summary & Verified Entry Point Signals - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

How sentiment analysis helps forecast Apellis Pharmaceuticals Inc.Quarterly Profit Review & Step-by-Step Trade Execution Guides - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Can Apellis Pharmaceuticals Inc. stock sustain market leadership2025 Market Outlook & Weekly Breakout Watchlists - Fundação Cultural do Pará

Oct 27, 2025
pulisher
Oct 27, 2025

How Apellis Pharmaceuticals Inc. stock performs in weak economyMarket Growth Summary & Breakout Confirmation Alerts - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Will Apellis Pharmaceuticals Inc. stock gain from lower inflation2025 Price Targets & Reliable Breakout Stock Forecasts - newser.com

Oct 27, 2025

아펠리스 (APLS) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

아펠리스 주식 (APLS) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Sullivan Timothy Eugene
Chief Financial Officer
Oct 21 '25
Sale
28.03
10,000
280,300
110,936
$36.45
price up icon 0.12%
$89.49
price down icon 2.47%
$28.77
price down icon 1.34%
$103.42
price down icon 1.46%
biotechnology ONC
$313.73
price down icon 0.98%
$165.37
price up icon 0.13%
자본화:     |  볼륨(24시간):